Eli Lilly and Company shared positive results from the main overall survival analysis of the Phase 3 monarchE trial. These results show that adding Verzenio
Series A co-led by founding investor M Ventures and new lead investors Hadean Ventures, Sofinnova Partners, and 4BIO Capital with syndicate including Bioqube Ventures, Surveyor Capital
Phase 1b study suggests a promising safety profile and highlights the potential of a novel dual-targeting CD19/CD20 CAR T in patients with relapsed or refractory disease Johnson
A clinically guided HRT offering featuring estradiol cream, patches, and compounded progesterone is now available via Eden’s platform in most U.S. states. Eden, the leading
Oral presentation at Rehab Week will share customer data from initial system deployment Bioliberty, a medtech startup transforming the delivery of physical and occupational therapy,
Optime Care, a nationally recognized specialty pharmacy and an AscellaHealth Company, today announces an expanded partnership with Eton Pharmaceuticals (“Eton”), an innovative pharmaceutical company focused on developing and commercializing
